Ginkgo Bioworks Holdings, Inc. (DNA) News
Filter DNA News Items
DNA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DNA News Highlights
- DNA's 30 day story count now stands at 19.
- Over the past 23 days, the trend for DNA's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- LYFT, MRNA and XWEL are the most mentioned tickers in articles about DNA.
Latest DNA News From Around the Web
Below are the latest news stories about GINKGO BIOWORKS HOLDINGS INC that investors may wish to consider to help them evaluate DNA as an investment opportunity.
That Will Motivate You Today: Lyft, Inc. (NASDAQ:LYFT 3.66%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -2.76%)LYFT has seen its SMA50 which is now 34.01%. In looking the SMA 200 we see that the stock has seen a -2.22%. DNA has seen its SMA50 which is … The post That Will Motivate You Today: Lyft, Inc. (NASDAQ:LYFT 3.66%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -2.76%) appeared first on Stocks Equity . |
Stocks in News: Huntington Bancshares Incorporated (NASDAQ:HBAN -0.36%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -8.74%)There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Stocks in News: Huntington Bancshares Incorporated (NASDAQ:HBAN -0.36%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -8.74%) appeared first on Stocks Equity . |
Two Stocks Disappointing Investors: The Kraft Heinz Company (NASDAQ:KHC -6.31%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -8.04%)There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Two Stocks Disappointing Investors: The Kraft Heinz Company (NASDAQ:KHC -6.31%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -8.04%) appeared first on Stocks Equity . |
NAMUH and Ginkgo Bioworks Announce Partnership to Produce Multiple Infant Nutrition ProductsNAMUH, an infant nutrition company, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk. |
Ginkgo Bioworks Partners With Ukraine on Wastewater Testing; CDC on Flu MonitoringThe announcements come a week after Ginkgo announced that it would meet its full-year 2022 revenue guidance on the strength of biosecurity revenues. |
Ginkgo Bioworks and XpresCheck Expand CDC’s Traveler-Based Genomic Surveillance Program to Detect Influenza VariantsThe program is an effective early warning system for viral variants, leveraging voluntary sampling from international travelers at major U.S. airports BOSTON and NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Ginkgo Bioworks (NYSE: DNA) and XWELL, Inc. (Nasdaq: XWEL) today announced that they have expanded their support for the Centers for Disease Control and Prevention’s (CDC’s) Traveler-based |
Ginkgo Bioworks and the Public Health Center of the Ukraine Ministry of Health Announce Collaboration to Implement Biosecurity Capabilities in UkraineGinkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and the Public Health Center of the Ukraine Ministry of Health today announced a new collaboration to conduct a wastewater testing pilot program in Ukraine with the intent to help provide early warning for infectious disease outbreaks and enable rapid and strategic public health intervention. |
3 Penny Stocks That Could Rise 500% in 2023Tilt the odds in your favor in 2023 with some of these high-potential penny stocks. |
Ginkgo Bioworks: Increasing Focus On Pharma And BiotechGinkgo''s Foundry business continues to expand, although the long-term economics remain uncertain. Click here to read my analysis of DNA stock. |
Ginkgo Bioworks Holdings Insider Trades Send a SignalBarry Canton , 10% Owner at Ginkgo Bioworks Holdings (NYSE: DNA ), reported a large insider sell on January 10, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Canton sold 608,506 shares of Ginkgo Bioworks Holdings . The total transaction amounted to $915,194. Ginkgo Bioworks Holdings shares are trading up 3.25% at $1.59 at the time of this writing on Wednesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used … Full story available on Benzinga.com |